Effects of drugs and drug metabolites on erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient individuals.
D000083:Acetanilides / Q000378:metabolism / Q000494:pharmacology; D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D000962:Antimalarials / Q000378:metabolism* / Q000494:pharmacology; D001555:Benzene Derivatives / Q000494:pharmacology; D044383:Black People; D002462:Cell Membrane / Q000187:drug effects; D004285:Dogs; D004912:Erythrocytes / Q000032:analysis / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D005260:Female; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000097:blood / Q000378:metabolism*; D005978:Glutathione / Q000032:analysis; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008706:Methemoglobin / Q000032:analysis; D009249:NADP / Q000032:analysis; D009603:Nitroso Compounds / Q000494:pharmacology; D009996:Osmotic Fragility / Q000187:drug effects; D011319:Primaquine / Q000378:metabolism; D014556:Urine / Q000032:analysis
D000083:Acetanilides; D000814:Aniline Compounds; D000962:Antimalarials; D001555:Benzene Derivatives; D009603:Nitroso Compounds; D009249:NADP; D008706:Methemoglobin; D005978:Glutathione; D011319:Primaquine